Physician profile
Gene Yang
NPI 1568807089
$8,779.94
in general payments reported to CMS, 2019-2025
17 companies · $5,909 in 2025
The $5,909 reported for 2025 was more than what 92% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $43.17 · 2022: $302 · 2023: $1,777 · 2024: $749 · 2025: $5,909.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,550 · Travel and Lodging: $2,080 · Food and Beverage: $1,804.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,550.00 |
| Travel and Lodging | $2,080.20 |
| Food and Beverage | $1,804.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $5,847.94 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| W. L. Gore & Associates, INC. | $829.56 | 2023 | Gore Bio-A Tissue Reinforcement, Gore Synecor Biomaterial |
| Apollo Endosurgery US INC | $538.07 | 2023 | Overstitch Endoscopic Suturing System |
| Intuitive Surgical, INC. | $400.33 | 2024 | |
| Lucid Diagnostics INC. | $310.81 | 2023 | |
| Stryker Corporation | $194.88 | 2022-2024 | Aim (Advanced Imaging Modality) |
| Endogastric Solutions, INC | $145.68 | 2024 | Esophyx |
| Medtronic, INC. | $127.47 | 2022 | |
| Becton, Dickinson and Company | $77.00 | 2023 | Phasix Mesh |
| Boston Scientific Corporation | $68.37 | 2023-2024 | Spyglass Discover, Exalt Model D |
| Novo Nordisk INC | $56.75 | 2024-2025 | Wegovy |
| Ethicon US, LLC | $43.17 | 2020 | |
| Smith+Nephew, INC. | $41.85 | 2024 | Pico, Collagenase Santyl |
| Steris Corporation | $39.70 | 2024 | |
| Abbvie INC. | $27.84 | 2025 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $17.40 | 2025 | Zepbound |
| Mesh Suture INC | $13.12 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gene Yang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.